Summary
C97 Chart
Co-Diagnostics, Inc. (CODX) Q1 2025 Earnings Call Transcript
Co-Diagnostics, Inc. (NASDAQ:CODX ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Andrew Benson - Head, Investor Relations Dwight Egan - Chief Executive Officer Brian Brown - Chief Financial Officer Conference Call Participants Operator Thank you for standing by. My name is Cath and I will be your conference operator today.
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates
Co-Diagnostics, Inc. (CODX) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.31 per share a year ago.
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results
SALT LAKE CITY, May 08, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended March 31, 2025.
Co-Diagnostics Inc. Dividends
Co-Diagnostics Inc. Earnings
| 7 May 2025 Date | | - Cons. EPS | - EPS |
| 12 Mar 2025 Date | | - Cons. EPS | - EPS |
| 7 Nov 2024 Date | | - Cons. EPS | - EPS |
| 29 Aug 2024 Date | | - Cons. EPS | - EPS |
| 8 Aug 2024 Date | | - Cons. EPS | - EPS |
| 7 May 2025 Date | | - Cons. EPS | - EPS |
| 12 Mar 2025 Date | | - Cons. EPS | - EPS |
| 7 Nov 2024 Date | | - Cons. EPS | - EPS |
| 29 Aug 2024 Date | | - Cons. EPS | - EPS |
| 8 Aug 2024 Date | | - Cons. EPS | - EPS |
Co-Diagnostics Inc. (C97) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Co-Diagnostics Inc. ever had a stock split?
Co-Diagnostics Inc. Profile
| Medical - Devices Industry | Healthcare Sector | Mr. Dwight H. Egan CEO | XSTU Exchange | US1897631057 ISIN |
| US Country | 132 Employees | - Last Dividend | - Last Split | 12 Jul 2017 IPO Date |
Overview
Co-Diagnostics, Inc. is a pioneering molecular diagnostics company that engages in the development, manufacturing, and sale of reagents used for tests that function via the detection and/or analysis of nucleic acid molecules. Operating both in the United States and internationally, the company has carved a niche for itself in the field of diagnostic tests, focusing on a wide array of infectious diseases. Established in 2013 and based in Salt Lake City, Utah, Co-Diagnostics, Inc. has expanded its footprint globally, offering an extensive array of diagnostic solutions catering to several health concerns and industries. The company's commitment to innovation is evident in its offering of advanced molecular tools for the detection of infectious diseases, agricultural applications, and more.
Products and Services
Co-Diagnostics, Inc. offers an extensive range of products and services aimed at providing diagnostic solutions and advancing the field of molecular diagnostics. These include:
- Polymerase Chain Reaction (PCR) Diagnostic Tests: The company specializes in PCR diagnostic tests for a number of infectious diseases such as COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. These tests play a crucial role in the early detection and management of infectious diseases globally.
- Multiplexed Tests: Co-Diagnostics provides three multiplexed tests designed for testing mosquitos to identify various diseases they carry. This innovative approach aids in controlling and preventing the spread of mosquito-borne diseases.
- Molecular Tools: A wide range of molecular tools for the detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications are part of their offerings. These tools facilitate the accurate and timely diagnosis of diseases, contributing to better patient outcomes and agricultural productivity.
- Genetic Trait Identification Tests: The company offers tests that identify genetic traits in plant and animal genomes. This technology supports advancements in agriculture and livestock breeding by enabling the selection of desirable traits.
- Portable PCR Device: Co-Diagnostics has developed a portable PCR device designed to bring PCR diagnostic capabilities to patients in point-of-care and at-home settings. This innovation enhances access to diagnostic tests, making it convenient for users to receive timely health assessments.
- Diagnostic Equipment Sales: In addition to its proprietary diagnostic tests and devices, Co-Diagnostics intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. This expansion allows the company to offer comprehensive diagnostic solutions to its clients.
Contact Information
